When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ATAI - atai Life Sciences company Kures Therapeutics appoints Dr. Chad Beyer as CEO
ATAI Life Sciences N.V.
Kures Therapeutics, an atai Life Sciences ( NASDAQ: ATAI ) appoints of Chad E. Beyer, Ph.D., MBA, as CEO of Kures succeeding Dr. Srinivas Rao, effective July 1, 2022.
Dr. Srinivas Rao will continue to support and advise Kures’ programs from his role at atai Life Sciences.
Most recently Dr. Beyer served as senior VP of Research and Development at Promentis Pharmaceuticals.